Saturday, May 2, 2026

2025 Hope Sharing Campaign Shatters Fundraising Records, Raising Nearly 490 Billion won

The 2025 Hope Sharing Campaign raised 488.6 billion won, exceeding targets despite economic challenges, with increased individual donations.

Broadcom’s $1 Trillion Dream Shattered as Stock Drops 17% Amid DeepSeek Shock

Broadcom's stock plummeted 17.40% due to a shockwave from Chinese AI company DeepSeek, erasing significant market gains.

U.S.-Iran Tensions: What Does Trump’s Military Request Mean for South Korea?

As tensions rise, U.S. calls for allied contributions in the Strait of Hormuz prompt South Korea and Japan to navigate diplomatic challenges.

Jung Eun Kim

Author's Latest

ABL209: The Promising Dual Antibody ADC Revolutionizing Cancer Treatment in 2026

ABL Bio's ABL209 shows promising anti-cancer effects with broad safety in preclinical studies, advancing to Phase 1 trials in the U.S.

GC Biopharma Presents Aggregation Study of Alyglo IVIG… A New Benchmark for Safe Immunotherapy

GC Biopharma USA will present findings on IVIG formulations, highlighting Alyglo's lower protein aggregation and improved stability at NHIA 2026.

Discover the Truth of Beauty: How Rejuran is Redefining Skincare in 2026

PharmaResearch launched a video for Rejuran's campaign, emphasizing scientific truth in beauty and consumer trust in skincare.

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

Unlock Healthier Hair: JW Shinyak’s Ducray Neoptide Expert Shows 93.6% User Satisfaction in Global Study

JW Shinyak's Ducray Neoptide Expert shows significant hair improvement in a global trial, with high user satisfaction across ages and conditions.

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

Neurophet Unveils AI-Powered Alzheimer’s Treatment Software at ITEM 2026 in Japan

Neurophet showcases AI-driven brain disease tech at ITEM 2026 in Japan, partnering with Hokuyaku Takeyama to expand market reach.

Pet7 Launches Innovative Probiotic: A Comprehensive Guide for Dog Owners

Cha Bio F&C launches Pet7 Gut Care Probiotics to enhance canine digestive health with a blend of probiotics, prebiotics, and enzymes.

Samjin Pharmaceutical and Ewha Womans University Seoul Hospital Sign MOU for Innovative Migraine Treatment

Samjin Pharmaceutical partners with Ewha Womans University Medical Center to develop treatments for CNS disorders, focusing on migraines.

Lunit’s 200 Billion KRW Funding: How Atinum Investment Boosts AI in Healthcare

Lunit secures 30 billion KRW investment from Atinum to enhance global R&D and operations, reinforcing its position in medical AI.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

How is Omlyclo Revolutionizing Allergy Treatment in Europe: Key Successes and Insights

Celltrion's Omlyclo treatment is rapidly gaining market share in Europe, winning tenders and expanding prescriptions across multiple countries.

24-Hour Emergency Hotline: How GC’s New Service Supports Koreans in Vietnam

GC has partnered to launch a 24-hour emergency hotline for Koreans in Hanoi, enhancing access to medical services and support.

Unlocking the Future of Health: How Myokines Could Revolutionize Diabetes Management in 2026

HLB Life Care signs MOU to research myokines, aiming for innovations in health and functional foods with a focus on diabetes and aging.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.